| Mast cell–derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infection JB McLachlan, JP Hart, SV Pizzo, CP Shelburne, HF Staats, MD Gunn, ... Nature immunology 4 (12), 1199-1205, 2003 | 376 | 2003 |
| Tracking epitope-specific T cells JJ Moon, HH Chu, J Hataye, AJ Pagán, M Pepper, JB McLachlan, T Zell, ... Nature protocols 4 (4), 565-581, 2009 | 332 | 2009 |
| Salmonella infection: Interplay between the bacteria and host immune system JR Kurtz, JA Goggins, JB McLachlan Immunology letters 190, 42-50, 2017 | 289 | 2017 |
| On the composition of the preimmune repertoire of T cells specific for peptide–major histocompatibility complex ligands MK Jenkins, HH Chu, JB McLachlan, JJ Moon Annual review of immunology 28, 275-294, 2009 | 289 | 2009 |
| Mast cell activators: a new class of highly effective vaccine adjuvants JB McLachlan, CP Shelburne, JP Hart, SV Pizzo, R Goyal, ... Nature medicine 14 (5), 536-541, 2008 | 242 | 2008 |
| Dendritic cell antigen presentation drives simultaneous cytokine production by effector and regulatory T cells in inflamed skin JB McLachlan, DM Catron, JJ Moon, MK Jenkins Immunity 30 (2), 277-288, 2009 | 194 | 2009 |
| Mast cells augment adaptive immunity by orchestrating dendritic cell trafficking through infected tissues CP Shelburne, H Nakano, ALS John, C Chan, JB McLachlan, MD Gunn, ... Cell host & microbe 6 (4), 331-342, 2009 | 157 | 2009 |
| A naturally derived outer-membrane vesicle vaccine protects against lethal pulmonary Burkholderia pseudomallei infection W Nieves, S Asakrah, O Qazi, KA Brown, J Kurtz, DP AuCoin, ... Vaccine 29 (46), 8381-8389, 2011 | 137 | 2011 |
| Structure-activity relationships for xenobiotic transport substrates and inhibitory ligands of P-glycoprotein. LJ Bain, JB McLachlan, GA LeBlanc Environmental health perspectives 105 (8), 812-818, 1997 | 121 | 1997 |
| Memory B cells contribute to rapid Bcl6 expression by memory follicular helper T cells W Ise, T Inoue, JB McLachlan, K Kometani, M Kubo, T Okada, T Kurosaki Proceedings of the National Academy of Sciences 111 (32), 11792-11797, 2014 | 111 | 2014 |
| Temporal expression of bacterial proteins instructs host CD4 T cell expansion and Th17 development SJ Lee, JB McLachlan, JR Kurtz, D Fan, SE Winter, AJ Baumler, ... PLoS pathogens 8 (1), e1002499, 2012 | 107 | 2012 |
| CD4+ T cell persistence and function after infection are maintained by low-level peptide: MHC class II presentation RW Nelson, JB McLachlan, JR Kurtz, MK Jenkins The Journal of Immunology 190 (6), 2828-2834, 2013 | 93 | 2013 |
| Selective priming and expansion of antigen-specific Foxp3− CD4+ T cells during Listeria monocytogenes infection JM Ertelt, JH Rowe, TM Johanns, JC Lai, JB McLachlan, SS Way The Journal of Immunology 182 (5), 3032-3038, 2009 | 92 | 2009 |
| Salmonella Biofilm Formation, Chronic Infection, and Immunity Within the Intestine and Hepatobiliary Tract JE Harrell, MM Hahn, SJ D’Souza, EM Vasicek, JL Sandala, JS Gunn, ... Frontiers in cellular and infection microbiology 10, 624622, 2021 | 69 | 2021 |
| Chemokine receptor requirements for epidermal T-cell trafficking NJ Tubo, JB McLachlan, JJ Campbell The American journal of pathology 178 (6), 2496-2503, 2011 | 56 | 2011 |
| Molt‐independent growth inhibition of Daphnia magna by a vertebrate antiandrogen GA Leblanc, JB Mclachlan Environmental Toxicology and Chemistry: An International Journal 18 (7 …, 1999 | 47 | 1999 |
| POLE mutation spectra are shaped by the mutant allele identity, its abundance, and mismatch repair status KP Hodel, MJS Sun, N Ungerleider, VS Park, LG Williams, DL Bauer, ... Molecular cell 78 (6), 1166-1177. e6, 2020 | 45 | 2020 |
| Adjuvant selection regulates gut migration and phenotypic diversity of antigen-specific CD4+ T cells following parenteral immunization DR Frederick, JA Goggins, LM Sabbagh, LC Freytag, JD Clements, ... Mucosal immunology 11 (2), 549-561, 2018 | 42 | 2018 |
| Bacterial-derived outer membrane vesicles are potent adjuvants that drive humoral and cellular immune responses JT Prior, C Davitt, J Kurtz, P Gellings, JB McLachlan, LA Morici Pharmaceutics 13 (2), 131, 2021 | 35 | 2021 |
| In situ Treatment With Novel Microbiocide Inhibits Methicillin Resistant Staphylococcus aureus in a Murine Wound Infection Model JP Hoffmann, JK Friedman, Y Wang, JB McLachlan, MC Sammarco, ... Frontiers in Microbiology 10, 3106, 2020 | 35 | 2020 |
LISA MORICITulaneVerified email at tulane.edu
